These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19536307)

  • 1. Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.
    Saihan Z; Li Z; Rice J; Rana NA; Ramsden S; Schlottmann PG; Jenkins SA; Blyth C; Black GC; McKie N; Webster AR
    Mol Vis; 2009 Jun; 15():1218-30. PubMed ID: 19536307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes.
    Gliem M; Müller PL; Mangold E; Holz FG; Bolz HJ; Stöhr H; Weber BH; Charbel Issa P
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2664-76. PubMed ID: 25766588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
    Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
    Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy.
    Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ
    J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation at the N-terminal domain of the TIMP3 gene in Sorsby fundus dystrophy.
    Schoenberger SD; Agarwal A
    Retina; 2013 Feb; 33(2):429-35. PubMed ID: 23023527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
    Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
    J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
    Soboleva G; Geis B; Schrewe H; Weber BH
    J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.
    Naessens S; De Zaeytijd J; Syx D; Vandenbroucke RE; Smeets F; Van Cauwenbergh C; Leroy BP; Peelman F; Coppieters F
    Hum Mutat; 2019 May; 40(5):539-551. PubMed ID: 30668888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deglycosylation Increases the Aggregation and Angiogenic Properties of Mutant Tissue Inhibitor of Metalloproteinase 3 Protein: Implications for Sorsby Fundus Dystrophy.
    Qi JH; Anand-Apte B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorsby fundus dystrophy: Insights from the past and looking to the future.
    Anand-Apte B; Chao JR; Singh R; Stöhr H
    J Neurosci Res; 2019 Jan; 97(1):88-97. PubMed ID: 30129971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutation in the TIMP3 gene causes Sorsby fundus dystrophy.
    Jacobson SG; Cideciyan AV; Bennett J; Kingsley RM; Sheffield VC; Stone EM
    Arch Ophthalmol; 2002 Mar; 120(3):376-9. PubMed ID: 11879143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticular Pseudodrusen in Sorsby Fundus Dystrophy.
    Gliem M; Müller PL; Mangold E; Bolz HJ; Stöhr H; Weber BH; Holz FG; Charbel Issa P
    Ophthalmology; 2015 Aug; 122(8):1555-62. PubMed ID: 26077580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-Causing
    Vergaro A; Pankievic M; Jedlickova J; Dudakova L; Vajter M; Michaelides M; Meliska M; Nemec P; Babincova D; Kousal B; Liskova P
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
    Fogarasi M; Janssen A; Weber BH; Stöhr H
    Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.
    Wolk A; Hatipoglu D; Cutler A; Ali M; Bell L; Hua Qi J; Singh R; Batoki J; Karle L; Bonilha VL; Wessely O; Stoehr H; Hascall V; Anand-Apte B
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene.
    Ayyagari R; Griesinger IB; Bingham E; Lark KK; Moroi SE; Sieving PA
    Arch Ophthalmol; 2000 Jan; 118(1):85-92. PubMed ID: 10636420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Onset TIMP3-Related Retinopathy Associated With Impaired Signal Peptide.
    Guan B; Huryn LA; Hughes AB; Li Z; Bender C; Blain D; Turriff A; Cukras CA; Hufnagel RB
    JAMA Ophthalmol; 2022 Jul; 140(7):730-733. PubMed ID: 35679059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel
    DeBenedictis MJ; Gindzin Y; Glaab E; Anand-Apte B
    Ophthalmic Genet; 2020 Oct; 41(5):480-484. PubMed ID: 32715858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.